• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用最大后验概率贝叶斯拟合对药物剂量方案进行自适应控制。

Adaptive control of drug dosage regimens using maximum a posteriori probability Bayesian fitting.

作者信息

Proost J H

机构信息

Department of Pharmacokinetics and Drug Delivery, University Centre for Pharmacy, Groningen, The Netherlands.

出版信息

Int J Clin Pharmacol Ther. 1995 Oct;33(10):531-6.

PMID:8574501
Abstract

Optimal drug therapy can only be achieved if a drug is given in the right dosage regimen. Therefore the dosage regimen needs to be optimized, using the available information of the drug, the patient, and his disease. The optimization of drug therapy comprises two major steps: First, the clinician should define explicit therapeutic goals for each patient individually. Second, a strategy to achieve these goals with the greatest possible precision should be chosen. An overview of the optimization of drug therapy is presented, with special reference to maximum a posteriori probability (MAP) Bayesian fitting. Drug dosage optimization requires 1. measurement of a performance index related to the therapeutic goal, generally one or more plasma concentration measurements, 2. population pharmacokinetic parameters, including mean values, standard deviations, covariances and information on the statistical distribution, and 3. reliable software for adaptive control strategy and optimal dosage regimen calculation. The benefit of optimal drug therapy by adaptive control using MAP Bayesian fitting has been proven, resulting in improved patient outcome by improved efficacy of therapy and a reduction of adverse reactions, and in reduced costs, mainly due to a reduction of hospitalization. Newer strategies might replace the MAP Bayesian fitting procedure, if their advantage has been demonstrated convincingly, and if reliable and user-friendly software is available.

摘要

只有以正确的给药方案给予药物,才能实现最佳药物治疗。因此,需要利用药物、患者及其疾病的现有信息来优化给药方案。药物治疗的优化包括两个主要步骤:首先,临床医生应为每个患者单独确定明确的治疗目标。其次,应选择一种尽可能精确地实现这些目标的策略。本文概述了药物治疗的优化,特别提及最大后验概率(MAP)贝叶斯拟合。药物剂量优化需要:1. 测量与治疗目标相关的性能指标,通常是一次或多次血浆浓度测量;2. 群体药代动力学参数,包括均值、标准差、协方差以及统计分布信息;3. 用于自适应控制策略和最佳给药方案计算的可靠软件。通过使用MAP贝叶斯拟合进行自适应控制实现最佳药物治疗的益处已得到证实,这带来了治疗效果改善、不良反应减少从而改善患者预后,以及成本降低,主要是由于住院次数减少。如果新策略的优势得到令人信服的证明,并且有可靠且用户友好的软件,那么更新的策略可能会取代MAP贝叶斯拟合程序。

相似文献

1
Adaptive control of drug dosage regimens using maximum a posteriori probability Bayesian fitting.使用最大后验概率贝叶斯拟合对药物剂量方案进行自适应控制。
Int J Clin Pharmacol Ther. 1995 Oct;33(10):531-6.
2
Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control.个体化药物给药方案:群体药代动力学和动力学模型、贝叶斯拟合及自适应控制的作用
Ther Drug Monit. 1993 Oct;15(5):380-93.
3
Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.利用常规血清监测数据对癫痫患者丙戊酸药代动力学进行非参数群体建模:对剂量的影响
J Clin Pharm Ther. 2004 Apr;29(2):105-20. doi: 10.1111/j.1365-2710.2003.00538.x.
4
Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package.使用P-PHARM软件包进行群体药代动力学及最佳给药方案的条件评估。
Anticancer Res. 1994 Nov-Dec;14(6A):2321-6.
5
Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.危重症患者阿米卡星剂量个体化的群体药代动力学模型评估
J Pharm Pharmacol. 2009 Jun;61(6):759-66. doi: 10.1211/jpp/61.06.0008.
6
Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?治疗药物监测后个体化氨基糖苷类药物给药方案:简单还是复杂的药代动力学方法?
Clin Pharmacokinet. 2001;40(11):803-14. doi: 10.2165/00003088-200140110-00002.
7
[Can we use a Bayesian method to build a pharmacokinetic population in two steps?].我们能否分两步使用贝叶斯方法构建药代动力学群体?
Therapie. 2000 Mar-Apr;55(2):277-82.
8
Modeling, adaptive control, and optimal drug therapy.建模、自适应控制与最佳药物治疗。
Med Prog Technol. 1990 May;16(1-2):95-110.
9
Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.一种易于使用、准确且灵活的个体化贝叶斯有限采样方法,用于肝移植后环孢素监测,无需固定时间点。
Aliment Pharmacol Ther. 2005 Mar 1;21(5):549-57. doi: 10.1111/j.1365-2036.2005.02364.x.
10
A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.一种用于估计甲型血友病患者凝血因子 VIII 个体药代动力学参数的有限采样策略。
Ther Drug Monit. 2007 Feb;29(1):20-6. doi: 10.1097/FTD.0b013e3180311384.

引用本文的文献

1
Comparison of Vancomycin AUC24 Calculation Methods for Neonates and Infants.比较万古霉素 AUC24 在新生儿和婴儿中的计算方法。
Eur J Drug Metab Pharmacokinet. 2024 Nov;49(6):773-779. doi: 10.1007/s13318-024-00920-5. Epub 2024 Oct 22.
2
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin.基于模型的利福平个体化剂量调整实现结核病精准治疗。
Clin Pharmacokinet. 2019 Jun;58(6):815-826. doi: 10.1007/s40262-018-00732-2.
3
Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients.
中国成年肾移植受者中霉酚酸浓度的群体药代动力学及贝叶斯估计
Acta Pharmacol Sin. 2017 Nov;38(11):1566-1579. doi: 10.1038/aps.2017.115. Epub 2017 Aug 24.
4
External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.已发表的成人肾移植受者他克莫司群体药代动力学模型的外部评估。
Br J Clin Pharmacol. 2016 May;81(5):891-907. doi: 10.1111/bcp.12830. Epub 2016 Feb 26.
5
Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction.肝移植后早期他克莫司药代动力学及贝叶斯预测的临床应用
Eur J Clin Pharmacol. 2013 Jan;69(1):65-74. doi: 10.1007/s00228-012-1300-z. Epub 2012 Jun 3.
6
Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.环孢素在异基因造血干细胞移植中的群体药代动力学:重点关注有限采样策略。
Br J Clin Pharmacol. 2012 Apr;73(4):553-63. doi: 10.1111/j.1365-2125.2011.04116.x.
7
Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patients.基于贝叶斯方法预测成年肾移植患者的他克莫司血药浓度。
Eur J Drug Metab Pharmacokinet. 2011 Mar;36(1):25-33. doi: 10.1007/s13318-011-0027-z. Epub 2011 Feb 24.
8
Impact of gestational age and birth weight on amikacin clearance on day 1 of life.胎龄和出生体重对生后第 1 天阿米卡星清除率的影响。
Clin J Am Soc Nephrol. 2009 Nov;4(11):1774-8. doi: 10.2215/CJN.02230409. Epub 2009 Aug 27.
9
Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients.稳定期肾移植患者霉酚酸浓度的群体药代动力学及贝叶斯估计
Clin Pharmacokinet. 2004;43(4):253-66. doi: 10.2165/00003088-200443040-00004.
10
Bayesian forecasting in paediatric populations.儿科人群中的贝叶斯预测
Clin Pharmacokinet. 1996 Nov;31(5):325-30. doi: 10.2165/00003088-199631050-00001.